Kanser hastalarında sosyodemografik faktörler, klinik özellikler ve anksiyete düzeyleri arasındaki ilişki: Kesitsel bir çalışma

Year 2024, , 337 - 342, 30.09.2024

Armağan Aydın , Erkan Kayıkçıoğlu

https://doi.org/10.18663/tjcl.1464946

Abstract

Amaç: Kanser teşhisi bireylerin yaşamlarında derin etkiler bırakan bir dönüm noktasıdır; fiziksel ve duygusal zorlukları içerir. Bu çalışma, kanser hastalarının teşhisi sonrası psikolojik tepkilerini kapsamlı bir şekilde araştırmayı amaçlamaktadır.
Yöntem: Tıbbi onkoloji bölümünde 199 kanser hastasını içeren bu kesitsel çalışmada, Hamilton Anksiyete Ölçeği (HAM-A) anketi kullanılarak sosyodemografik ve klinik veriler toplandı. İstatistiksel analiz, anksiyete düzeylerini ve çeşitli faktörlerle olan ilişkilerini değerlendirdi.
Bulgular: Çalışma, yaş ortalaması 57.28±11.76 olan, %47.7'si erkek ve %52.3'ü kadın olan 199 vaka içeriyordu. Kadınlar, erkeklere kıyasla daha yüksek bir ortalama yaşa sahipti (sırasıyla 55.18±1.15 ve 59.58±1.17). Katılımcıların 165'i evliydi ve %41.2'si lise mezunuydu, %67.8'i ise çalışmıyordu. Kolorektal ve pankreatik-biliyer sistem tümörleri en yaygın olanıydı (%26.1), merkezi sinir sistemi tümörleri ise en az yaygın olanıydı (%0.5). Katılımcıların çoğunluğu (%59.3) metastatik kansere sahipti ve %55.8'i klasik kemoterapi alıyordu. Ortalama Hamilton Anksiyete Ölçeği (HAM-A) puanı 25.63±7.90 idi ve kadınlar, erkeklere kıyasla daha yüksek puan aldı (%26.67±0.77 ve %24.48±0.80, p=0.025). Katılımcıların %46.7'sinde hafif anksiyete gözlemlendi, %53.3'ünde ise ciddi anksiyete yaşandı. Genitoüriner sistem tümörleri en yüksek HAM-A puanına sahipti (%26.08±1.54), metastatik hastalar ve immünoterapi alanlar daha yüksek anksiyete seviyelerini bildirdi. Anksiyete puanları ile sosyodemografik faktörler, kanser türü, eşlik eden hastalıklar, kanser evresi, tedavi yöntemi, Eastern Cooperative Oncology Group Performans Durumu veya radyoterapi arasında anlamlı bir ilişki bulunamadı.
Sonuçlar: Çalışma, anksiyetede cinsiyet farklılıklarını vurgulayarak mevcut literatürle uyumludur. Cinsiyet dışındaki sosyodemografik faktörlerin anksiyete seviyeleriyle anlamlı bir ilişkisinin olmadığı ortaya çıkmıştır. Belirli kanser türleri ve ileri evreler daha yüksek anksiyete göstermiştir, psikososyal destek ihtiyacının özellikle bu gruptaki hastalarda desteklenmesini gerektirir. Bu araştırma, kanser hastalarında sosyodemografik faktörler, klinik özellikler ve anksiyete arasındaki karmaşık etkileşimi anlamamıza katkı sağlamaktadır.

Keywords

Kanser, anksiyete, Hamilton Anksiyete Ölçeği (HAM-A), sosyodemografik faktörler

Exploring the interplay between sociodemographic factors, clinical characteristics, and anxiety levels in cancer patients: a cross-sectional study

Abstract

Aim: The primary aim of this study was to examine the correlation between anxiety levels and the sociodemographic and clinical characteristics in cancer patients undergoing chemotherapy. Precisely identifying patient cohorts with varying psychological responses can substantially enhance cancer treatment through the improved integration of personalized therapeutic options.
Material and Methods: A cross-sectional study involving 199 cancer patients at a medical oncology department utilized a questionnaire and the Hamilton Anxiety Scale (HAM-A) to collect sociodemographic and clinical data. Statistical analysis assessed anxiety levels and their correlation with various factors.
Results: The study included 199 cases with an average age of 57.28±11.76 years, consisting of 47.7% males and 52.3% females. Women exhibited a higher average age (55.18±1.15 years) compared to men (59.58±1.17 years). Among the participants, 165 were married, and 41.2% were high school graduates, with 67.8% not employed. Colorectal and pancreaticobiliary system tumors were most common (26.1%), while central nervous system tumors were least common (0.5%). The majority (59.3%) had metastatic cancer, and 55.8% were undergoing classical chemotherapy. The average Hamilton Anxiety Scale (HAM-A) score was 25.63±7.90, with women scoring higher than men (26.67±0.77 vs. 24.48±0.80, p=0.025). Minor anxiety was observed in 46.7%, while 53.3% experienced major anxiety. Genitourinary system tumors had the highest HAM-A score (26.08±1.54), and metastatic patients and those undergoing immunotherapy reported higher anxiety levels. No significant relationships were found between anxiety scores and sociodemographic factors, cancer type, comorbidity, cancer stage, treatment method, Eastern Cooperative Oncology Group Performance Status, or radiotherapy.
Conclusions: The study highlighted gender differences in anxiety, aligning with existing literature. Sociodemographic factors, except gender, showed no significant correlation with anxiety levels. Specific cancer types and advanced stages demonstrated higher anxiety, emphasizing the need for targeted psychosocial support. This research contributes to understanding the complex interplay between sociodemographic factors, clinical characteristics, and anxiety in cancer patients. The findings support the development of targeted interventions for specific patient groups, aligning with the broader goal of providing empathetic and comprehensive cancer care.

Keywords

Cancer, Anxiety, Hamilton Anxiety Scale (HAM-A), Sociodemographic factors

References

• Dinapoli L, Colloca G, Di Capua B, Valentini V. Psychological Aspects to Consider in Breast Cancer Diagnosis and Treatment. Curr Oncol Rep. 2021;23(3):38. doi:10.1007/s11912-021-01049-3
• Tommasi C, Balsano R, Corianò M, et al. Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm? J Clin Med. 2022;11(23):7239. doi:10.3390/jcm11237239
• Wang L, Dong Q, Ye M, Du J, Zhou R, Cai X. Effect of Different Repair and Reconstruction Methods Combined with Psychological Intervention on Quality of Life and Negative Emotion in Patients with Oral Cancer. Comput Math Methods Med. 2022;2022:1-6. doi:10.1155/2022/7359584
• Aminisani N, Nikbakht HA, Shojaie L, Jafari E, Shamshirgaran M. Gender Differences in Psychological Distress in Patients with Colorectal Cancer and Its Correlates in the Northeast of Iran. J Gastrointest Cancer. 2022;53(2):245-252. doi:10.1007/s12029-020-00558-x
• Rodin G, An E, Shnall J, Malfitano C. Psychological Interventions for Patients With Advanced Disease: Implications for Oncology and Palliative Care. Journal of Clinical Oncology. 2020;38(9):885-904. doi:10.1200/JCO.19.00058
• Naser AY, Hameed AN, Mustafa N, et al. Depression and Anxiety in Patients With Cancer: A Cross-Sectional Study. Front Psychol. 2021;12. doi:10.3389/fpsyg.2021.585534
• Goerling U, Hinz A, Koch-Gromus U, Hufeld JM, Esser P, Mehnert-Theuerkauf A. Prevalence and severity of anxiety in cancer patients: results from a multi-center cohort study in Germany. J Cancer Res Clin Oncol. 2023;149(9):6371-6379. doi:10.1007/s00432-023-04600-w
• Vitale E, Halemani K, Shetty A, et al. Sex Differences in Anxiety and Depression Conditions among Cancer Patients: A Systematic Review and Meta-Analysis. Cancers (Basel). 2024;16(11):1969. doi:10.3390/cancers16111969
• Thompson E. Hamilton Rating Scale for Anxiety (HAM-A). Occup Med (Chic Ill). 2015;65(7):601-601. doi:10.1093/occmed/kqv054
• Matza LS, Morlock R, Sexton C, Malley K, Feltner D. Identifying HAM‐A cutoffs for mild, moderate, and severe generalized anxiety disorder. Int J Methods Psychiatr Res. 2010;19(4):223-232. doi:10.1002/mpr.323
• Safaie N, Zeinali H, Ghahramanfard F, Mirmohammadkhani M, Moonesan M. Anxiety and depression among new cancer patients. J Family Med Prim Care. 2022;11(8):4146. doi:10.4103/jfmpc.jfmpc_1984_21
• Belov OO, Dronenko VG, Rybinska VA, Tkach AA, Shevchuk T V. GENDER FEATURES OF DEPRESSIVE AND ANXIOUS MANIFESTATIONS OF THE LUNG CANCER PATIENTS. Wiadomości Lekarskie. 2022;75(2):393-396. doi:10.36740/WLek202202112
• Geue K, Göbel P, Leuteritz K, et al. Anxiety and depression in young adult German cancer patients: Time course and associated factors. Psychooncology. 2019;28(10):2083-2090. doi:10.1002/pon.5197
• Cheng V, Oveisi N, McTaggart-Cowan H, Loree JM, Murphy RA, De Vera MA. Colorectal Cancer and Onset of Anxiety and Depression: A Systematic Review and Meta-Analysis. Current Oncology. 2022;29(11):8751-8766. doi:10.3390/curroncol29110689
• Parás-Bravo P, Paz-Zulueta M, Boixadera-Planas E, et al. Cancer Patients and Anxiety: A Gender Perspective. Int J Environ Res Public Health. 2020;17(4):1302. doi:10.3390/ijerph17041302
• Götze H, Friedrich M, Taubenheim S, Dietz A, Lordick F, Mehnert A. Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis. Supportive Care in Cancer. 2020;28(1):211-220. doi:10.1007/s00520-019-04805-1
• Bradt J, Dileo C, Myers-Coffman K, Biondo J. Music interventions for improving psychological and physical outcomes in people with cancer. Cochrane Database of Systematic Reviews. 2021;2022(9). doi:10.1002/14651858.CD006911.pub4
• Huynh NTT, Fan SY, Kao CY. Nurse-led educational interventions for anxiety management in cancer survivors: a systematic review and meta-analysis. Supportive Care in Cancer. 2022;30(8):6699-6744. doi:10.1007/s00520-022-07085-4
• Yu J, Han M, Miao F, Hua D. Using mindfulness-based stress reduction to relieve loneliness, anxiety, and depression in cancer patients: A systematic review and meta-analysis. Medicine. 2023;102(37):e34917. doi:10.1097/MD.0000000000034917